v1
Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40(+) and CD40(-) plasmacytoma cells.
Identifier:nobleid.org/w1/20260515/08D599CE
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/08D599CE)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims